Schedule 13G ownership disclosure

CYCLACEL PHARMACEUTICALS INC

Security class unavailable · CUSIP: 23254L801

Event date: 2023-12-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
82,032
Percent of class
8.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001999371-24-000308
Form type
SC 13G
Filer
Altium Capital Management LLC
CIK
CIK 1746382
Filed
Jan 10, 2024
Reporting period
Dec 21, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub